Fisher & Paykel Healthcare Corporation Limited

Symbol: FPH.AX

ASX

23.66

AUD

Market price today

  • 61.8116

    P/E Ratio

  • 3.7087

    PEG Ratio

  • 13.82B

    MRK Cap

  • 0.01%

    DIV Yield

Fisher & Paykel Healthcare Corporation Limited (FPH-AX) Stock Price & Analysis

Shares Outstanding

0M

Gross Profit Margin

0.60%

Operating Profit Margin

0.22%

Net Profit Margin

0.15%

Return on Assets

0.11%

Return on Equity

0.14%

Return on Capital Employed

0.18%

Company general description and statistics

Sector: Healthcare
Industry: Medical - Instruments & Supplies
CEO:Mr. Lewis G. Gradon
Full-time employees:6391
City:Auckland
Address:15 Maurice Paykel Place
IPO:2001-11-20
CIK:

Fisher & Paykel Healthcare Corporation Limited, together with its subsidiaries, designs, manufactures, markets, and sells medical device products and systems worldwide. It also provides its products for use in acute and chronic respiratory care, and surgery, as well as the treatment of obstructive sleep apnea (OSA) in the home and hospital. The company offers Airvo 2, a humidified nasal high flow system; Optiflow, a nasal high flow therapy; and F&P 850 System, a noninvasive and invasive ventilation system. In addition, it provides infant respiratory products, such as resuscitation, continuous positive airway pressure (CPAP) therapy, and nasal high flow therapy products. Further, the company offers hospital products, including humidification products, breathing circuits, chambers, masks, nasal cannulas, surgical, accessories, and interfaces; and homecare products that include masks, CPAP devices, software and data management products, humidifiers, and accessories. Fisher & Paykel Healthcare Corporation Limited was founded in 1934 and is headquartered in Auckland, New Zealand.

General Outlook

When we look at how much money they make before expenses, they keep 0.601% as profit. This shows they're good at controlling costs and are financially stable. Their operating profit, which is money made from regular business activities, is 0.219%. This means they run their business efficiently. Lastly, after paying all their bills, they still have a profit of 0.153%. This tells us they're good at keeping money after all costs.

Return on Investments

The company's asset efficiency, represented by a robust 0.110% return, is a testament to Fisher & Paykel Healthcare Corporation Limited's adeptness in optimizing resource deployment. Fisher & Paykel Healthcare Corporation Limited's utilization of its assets to generate profits is strikingly evident through a noteworthy return on equity of 0.144%. Furthermore, the proficiency of Fisher & Paykel Healthcare Corporation Limited in capital utilization is underscored by a remarkable 0.178% return on capital employed.

Stock Prices

Fisher & Paykel Healthcare Corporation Limited's stock prices have been subject to undulating patterns. The peak stock value during this interval surged to $25.7, while its low point bottomed out at $25.3. This variance in figures offers investors a lucid insight into the roller-coaster ride that is Fisher & Paykel Healthcare Corporation Limited's stock market.

Liquidity Ratios

Analyzing FPH.AX liquidity ratios reveals its financial health of the firm. The current ratio of 254.25% gauges short-term asset coverage for liabilities. The quick ratio (105.89%) assesses immediate liquidity, while the cash ratio (24.58%) indicates cash reserves.

cards.indicatorcards.value
Current Ratio254.25%
Quick Ratio105.89%
Cash Ratio24.58%

Profitability Ratios

FPH.AX profitability indicators offer a lens into its earnings landscape. A pretax profit margin of 20.73% underscores its earnings before tax deductions. The effective tax rate stands at 26.14%, revealing its tax efficiency. The net income per EBT, 73.86%, and the EBT per EBIT, 94.80%, provide insights into its earnings hierarchy. Lastly, with an EBIT per revenue ratio of 21.86%, we grasp its operational profitability.

cards.indicatorcards.value
Pretax Profit Margin20.73%
Effective Tax Rate26.14%
Net Income per EBT73.86%
EBT per EBIT94.80%
EBIT per Revenue21.86%

Operational Efficiency

Operational metrics shed light on its business agility. With an operating cycle of 2.54, it details the span from stock purchase to revenue. The 1 days it takes to settle debts showcases its creditor relations.

cards.indicatorcards.value
Days of Sales Outstanding106
Days of Inventory Outstanding192
Operating Cycle241.84
Days of Payables Outstanding113
Cash Conversion Cycle128
Receivables Turnover7.34
Payables Turnover3.22
Inventory Turnover1.90
Fixed Asset Turnover1.21
Asset Turnover0.72

Cash Flow Ratios

Peering into the cash flow metrics reveals liquidity and operational efficiency. The operating cash flow per share, 0.63, and free cash flow per share, 0.05, depict cash generation on a per-share basis. The cash per share value, 0.11, showcases liquidity position. A payout ratio of 0.56 highlights the portion of earnings distributed as dividends. Lastly, the operating cash flow sales ratio, 0.23, offers insight into cash flow relative to sales.

cards.indicatorcards.value
Operating Cash Flow per Share0.63
Free Cash Flow per Share0.05
Cash per Share0.11
Payout Ratio0.56
Operating Cash Flow Sales Ratio0.23
Free Cash Flow to Operating Cash Flow Ratio0.08
Cash Flow Coverage Ratio1.29
Short Term Coverage Ratio66.71
Capital Expenditure Coverage Ratio1.09
Dividend Paid and Capex Coverage Ratio0.77
Dividend Payout Ratio0.01

Debt and Leverage Ratios

Diving into debt and leverage metrics unveils the company's financial structure. The debt ratio, at 12.78%, highlights its total liabilities relative to assets. With a debt-equity ratio of 0.17, we discern the balance between debt and equity financing. The long-term debt to capitalization, 14.60%, and total debt to capitalization, 14.85%, ratios shed light on its capital structure. An interest coverage of 26.34 indicates its ability to manage interest expenses.

cards.indicatorcards.value
Debt Ratio12.78%
Debt Equity Ratio0.17
Long Term Debt to Capitalization14.60%
Total Debt to Capitalization14.85%
Interest Coverage26.34
Cash Flow to Debt Ratio1.29
Company Equity Multiplier1.36

Per Share Data

Speaking about the per share data offers a perceptive view of financial distribution. The revenue per share, 2.57, provides a glimpse into top-line earnings distributed across each share. Net income per share, 0.43, reflects the portion of profit attributed to each share. The book value per share, 2.84, represents the net asset value distributed per share, while the tangible book value per share, 2.70, excludes intangible assets.

cards.indicatorcards.value
Revenue Per Share2.57
Net Income Per Share0.43
Book Value Per Share2.84
Tangible Book Value Per Share2.70
Shareholders Equity Per Share2.84
Interest Debt Per Share0.17
Capex Per Share-0.34

Growth Ratios

Delving into growth metrics provides a snapshot of financial expansion. The revenue growth rate, -15.70%, indicates top-line expansion, while the gross profit growth, -17.11%, reveals profitability trends. EBIT growth, -29.60%, and operating income growth, -29.60%, offer insights into operational profitability progression. The net income growth, -28.10%, showcases bottom-line expansion, and the EPS growth, -28.57%, measures the growth in earnings per share.

cards.indicatorcards.value
Revenue Growth-15.70%
Gross Profit Growth-17.11%
EBIT Growth-29.60%
Operating Income Growth-29.60%
Net Income Growth-28.10%
EPS Growth-28.57%
EPS Diluted Growth-27.78%
Weighted Average Shares Growth0.23%
Dividends per Share Growth23.77%
Operating Cash Flow Growth-84.65%
Free Cash Flow Growth-116.75%
10-Year Revenue Growth per Share201.68%
5-Year Revenue Growth per Share68.24%
3-Year Revenue Growth per Share52.09%
10-Year Operating CF Growth per Share28.98%
3-Year Operating CF Growth per Share-62.37%
10-Year Net Income Growth per Share355.75%
5-Year Net Income Growth per Share95.78%
3-Year Net Income Growth per Share78.86%
10-Year Shareholders Equity Growth per Share320.45%
5-Year Shareholders Equity Growth per Share117.96%
3-Year Shareholders Equity Growth per Share82.61%
10-Year Dividend per Share Growth per Share194.86%
5-Year Dividend per Share Growth per Share116.78%
3-Year Dividend per Share Growth per Share94.83%
Receivables Growth-21.62%
Inventory Growth32.63%
Asset Growth1.54%
Book Value per Share Growth10.19%
Debt Growth-11.91%
R&D Expense Growth12.66%

Other Metrics

Venturing into other key metrics unveils diverse facets of financial performance. The enterprise value, 15,418,527,094.032, captures the company's total value, considering both debt and equity. Income quality, 0.95, assesses the reliability of reported earnings. The sales, general, and administrative to revenue ratio, -0.02, gauges operational efficiency, while the research and development to revenue, 10.97%, highlights investment in innovation. The ratio of intangibles to total assets, 3.88%, indicates the value of non-physical assets, and capex to operating cash flow, -88.71%, measures reinvestment capability.

cards.indicatorcards.value
Enterprise Value15,418,527,094.032
Income Quality0.95
Sales General and Administrative to Revenue-0.02
Research and Development to Revenue10.97%
Intangibles to Total Assets3.88%
Capex to Operating Cash Flow-88.71%
Capex to Revenue-13.30%
Capex to Depreciation-213.43%
Stock-Based Compensation to Revenue0.57%
Graham Number5.26
Return on Tangible Assets12.62%
Graham Net Net0.07
Working Capital453,386,807
Tangible Asset Value1,561,020,883
Net Current Asset Value302,413,867
Average Receivables203,577,084.5
Average Payables45,040,078
Average Inventory337,408,707.5
Days Sales Outstanding58
Days Payables Outstanding24
Days of Inventory On Hand208
ROIC13.98%
ROE0.15%

Valuation Ratios

Exploring the valuation ratios offers insights into perceived market value. The price to book value ratio, 9.25, and the price to book ratio, 9.25, reflect the market's valuation relative to the company's book value. The price to sales ratio, 9.52, provides a perspective on valuation in relation to sales. Ratios like price to free cash flows, 518.30, and price to operating cash flows, 41.18, gauge market valuation against cash flow metrics.

cards.indicatorcards.value
Price Book Value Ratio9.25
Price to Book Ratio9.25
Price to Sales Ratio9.52
Price Cash Flow Ratio41.18
Price Earnings to Growth Ratio3.71
Enterprise Value Multiple33.65
Price Fair Value9.25
Price to Operating Cash Flow Ratio41.18
Price to Free Cash Flows Ratio518.30
Price to Tangible Book Ratio9.38
Enterprise Value to Sales10.37
Enterprise Value Over EBITDA37.55
EV to Operating Cash Flow69.16
Earnings Yield1.63%
Free Cash Flow Yield0.16%
security
Trusted project
“All information displayed on the site is verified. High quality project and financial performance”
Eugene Alexeev
NumFin Founder and investing enthusiast

Frequently Asked Question

How many company shares are outstanding in 2024?

There are stock number shares outstanding of Fisher & Paykel Healthcare Corporation Limited (FPH.AX) on the ASX in 2024.

What is P/E ratio of enterprise in 2024?

The current P/E ratio of enterprise is 61.812 in 2024.

What is the ticker symbol of Fisher & Paykel Healthcare Corporation Limited stock?

The ticker symbol of Fisher & Paykel Healthcare Corporation Limited stock is FPH.AX.

What is company IPO date?

IPO date of Fisher & Paykel Healthcare Corporation Limited is 2001-11-20.

What is company current share price?

Current share price is 23.660 AUD.

What is stock market cap today?

The market cap of stock today is 13816588240.000.

What is PEG ratio in 2024?

The current 3.709 is 3.709 in 2024.

What is the number of employees in 2024?

In 2024 the company has 6391.